Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 395 of 1,261
  1. US 10787472

    Prodrugs of pyridone amides useful as modulators of sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Sep 29, 2020 · Expires Sep 24, 2040

    granted
  2. US 10786552

    Il-2Rβ-selective agonists in combination with an anti-CTLA-4 antibody or an anti-PD-1 antibody

    Nektar Therapeutics · Granted Sep 29, 2020 · Expires Sep 24, 2040

    granted
  3. US 10785968

    Genetically modified non-human animals and methods of use thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 29, 2020 · Expires Sep 24, 2040

    granted
  4. US 10787413

    Derivatives of curcuminoids and use thereof as an anticancer agent

    China Medical University · Granted Sep 29, 2020 · Expires Sep 24, 2040

    granted
  5. US 10787490

    Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases

    Protagonist Therapeutics, Inc. · Granted Sep 29, 2020 · Expires Sep 24, 2040

    granted
  6. US 10786520

    Aminoglycoside derivatives and uses thereof in treating genetic disorders

    ELOXX PHARMACEUTICALS LTD. · Granted Sep 29, 2020 · Expires Sep 24, 2040

    granted
  7. US 10787499

    EpCAM targeted polypeptides, conjugates thereof, and methods of use thereof

    Regents of the University of Minnesota · Granted Sep 29, 2020 · Expires Sep 24, 2040

    granted
  8. US 10787501

    Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 29, 2020 · Expires Sep 24, 2040

    granted
  9. US 10786554

    Factor VIII polypeptide formulations

    BIOVERATIV THERAPEUTICS INC. · Granted Sep 29, 2020 · Expires Sep 24, 2040

    granted
  10. US 10787452

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Sep 29, 2020 · Expires Sep 24, 2040

    granted
  11. US 10786582

    Gd(III)-dithiolane gold nanoparticle conjugates

    Northwestern University · Granted Sep 29, 2020 · Expires Sep 24, 2040

    granted
  12. US 10785966

    Humanized M-CSF mice

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 29, 2020 · Expires Sep 24, 2040

    granted
  13. US 10787419

    Cannabinoid receptor mediating iminopyrazole compounds

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 29, 2020 · Expires Sep 24, 2040

    granted
  14. US 10787446

    Therapeutic compounds and methods of use thereof

    Xenon Pharmaceuticals Inc. · Granted Sep 29, 2020 · Expires Sep 24, 2040

    granted
  15. US 10787439

    Compounds and methods for activating the apoptotic arm of the unfolded protein response

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Sep 29, 2020 · Expires Sep 24, 2040

    granted
  16. US 10787449

    Octahydro fused azadecalin glucocorticoid receptor modulators

    Corcept Therapeutics Incorporated · Granted Sep 29, 2020 · Expires Sep 24, 2040

    granted
  17. US 10787462

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Sep 29, 2020 · Expires Sep 24, 2040

    granted
  18. US 10788490

    Dried cellulose-treated tissue for in-vitro complement activation assays and diagnostic kits

    ST. JUDE MEDICAL, CARDIOLOGY DIVISION, INC. · Granted Sep 29, 2020 · Expires Sep 24, 2040

    granted
  19. US 10787647

    HSD17B13 variants and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 29, 2020 · Expires Sep 24, 2040

    granted
  20. US 10786545

    Use of peptides that block metadherin-SND1 interaction as treatment for cancer

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Sep 29, 2020 · Expires Sep 24, 2040

    granted
  21. US 10786566

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Sep 29, 2020 · Expires Sep 24, 2040

    granted
  22. US 10786501

    Treatment of prostate cancer

    Takeda Pharmaceutical Company Limited · Granted Sep 29, 2020 · Expires Sep 24, 2040

    granted
  23. US 10786435

    Composition for optical three-dimensional modeling

    KURARAY NORITAKE DENTAL INC. · Granted Sep 29, 2020 · Expires Sep 24, 2040

    granted
  24. US 10786495

    Vesicular monoamine transporter 2 inhibitors for treating stuttering

    The Regents of the University of California · Granted Sep 29, 2020 · Expires Sep 24, 2040

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.